U.S. Markets closed

Item 9 Labs Corp. (INLB)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
3.5000+0.4500 (+14.75%)
At close: 3:58PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close3.0500
Open3.2000
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range2.9000 - 3.5000
52 Week Range0.1100 - 3.7500
Volume68,606
Avg. Volume14,658
Market Cap219.504M
Beta (5Y Monthly)0.19
PE Ratio (TTM)N/A
EPS (TTM)-0.1990
Earnings DateJan 12, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Why Experts Believe 2021 is Anticipated to be a Strong Year For Cannabis Industry
    PR Newswire

    Why Experts Believe 2021 is Anticipated to be a Strong Year For Cannabis Industry

    January 13, 2021 - It's that time of the year when various articles and reports look back on the U.S. and Canadian 2020 cannabis markets' performance. Many agree that while both markets performed well in toto they say that the cannabis industry had a strong year with the U.S. markets significantly outperforming Canadian peers. The cannabis sector just finished a strong 2020 with the U.S. market soaring while many Canadian stocks struggled. An recent article said: "Looking into 2021, we think the theme will continue to play out as the world's two largest cannabis markets face divergent outlooks. More importantly, within each market, there are certain companies positioned better to thrive and some will continue to struggle." The article continued: "We expect the U.S. cannabis sector and U.S.-focused ETFs to outperform again in 2021 due to several reasons. First of all, the size of the prize in Canada is too small. The Canadian adult-use market reached US$2.5B in October 2020 which is smaller than California's legal market in 2019 estimated at $2.8B. The California market is expected to reach $4B in 2020. While the Canadian market has also doubled its monthly sales during the pandemic, so did the U.S. markets. All in all, the U.S. is a much larger market and it is estimated to be almost 10x the size of the Canadian market." Active Companies active today in the cannabis related markets include: Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), Item 9 Labs Corp. (OTCQX: INLB), Jushi Holdings Inc (OTCQB: JUSHF) (CSE: JUSH), KushCo Holdings, Inc. (OTCQX: KSHB), Aphria Inc. (NASDAQ: APHA) (TSX: APHA).

  • Item 9 Labs Reports Record Revenue for Fiscal Year 2020
    PR Newswire

    Item 9 Labs Reports Record Revenue for Fiscal Year 2020

    Item 9 Labs Corp. (OTCQX: INLB) ("Item 9 Labs" or the "Company"), a vertically integrated cannabis operator that produces premium products, today reported the Company's operating and financial results for the fiscal year (FY) ended September 30, 2020.

  • Item 9 Labs Finalizes Merger Agreement with U.S. Cannabis Franchisor
    PR Newswire

    Item 9 Labs Finalizes Merger Agreement with U.S. Cannabis Franchisor

    Item 9 Labs Corp. (OTCQX: INLB) ("Item 9 Labs," or the "Company"), a vertically integrated cannabis operator that produces premium products, announced today that it has finalized its merger agreement with ONE Cannabis Group (OCG, Inc.) and expects to close the merger in January 2021.